Newsletter | October 8, 2026

10.08.26 -- Risk Managing Through The Void Of ATMP Visible Particle Guidance

SPONSOR

 

How rescue strategies shape retinal trial outcomes

In retinal vascular disease trials, rescue treatment is more than a safety measure. The criteria you choose can influence durability endpoints and how efficacy is interpreted. Discover the five core protocol decisions sponsors should align to preserve participants' vision and support a robust assessment of treatment efficacy and durability. Learn the five key decisions in retinal rescue strategy design.

FOCUS ON MANUFACTURING

Risk Managing Through The Void Of ATMP Visible Particle Guidance

Regulators expect cell therapy manufacturers to prove they control for visible particles, but guidance remains notably quiet on the matter. Companies must get creative or risk clinical holds.

 

 

lamp Pre- And Post-Gamma Extended Leak Tightness Study

Pressure and gamma irradiation testing demonstrated consistent, leak-tight connections without re-tightening for stored single-use assemblies.

 

Pouching Solutions For Sterile And Moisture-Sensitive Devices

Aseptic pouching requires specialized mechanical segregation and sterile vacuum handling. Discover how targeted engineering maintains Grade A compliance.

 

Quantifying CD73 Content And Function Across A Scalable MSC-EV Process

See how orthogonal analytical assays for CD73 content and enzymatic function can serve as critical quality attributes in scalable MSC-EV manufacturing.

 

Supporting The Future Of cGMP Drug Product Manufacturing

Read how holistic training and validation services help manufacturers navigate complex regulatory demands and achieve operational readiness faster.

 

How Platform Technologies Solve Large-Scale Viral Vector Challenges

Delve into the details of several platform technologies currently being developed and implemented to support effective, large-scale production of viral vectors that meet set quality attributes.

 

A Guide To Matching Bioprocess Filters To Viral Filtration And TFF Workflows

Explore a practical guide to selecting filters for bioprocessing applications that are matched to product type, process stage, and performance needs such as virus filtration, clarification, and TFF.

 

Scaling AAV And Oncolytic Virus Production With Fixed-Bed Systems

Fixed-bed bioreactors support scalable manufacturing of AAV and oncolytic virus therapies, offering proven process development strategies for successful clinical scale-up.

 

Modernizing Cleanrooms With IoT-Driven Smart Building Management Systems

IoT-enabled smart BMS modernize biopharmaceutical cleanrooms through continuous monitoring, predictive analytics, energy efficiency, and strengthened compliance, enabling safer, more efficient operations.

 

Applying Quality By Design Rules To Automated Packaging Platforms

Applying Quality by Design principles to automated packaging platforms leverages robotics to eliminate manual errors and adapt seamlessly to evolving regulatory requirements.

 

Non-Viral And Large-Scale Delivery Of Gene Editing Tools

Advanced electroporation platforms enable reliable, large-scale delivery of complex gene editing tools like CRISPR/Cas9 to improve efficiency in primary T-cell manufacturing.

 

Science- And Risk-Based Bio-Decontamination Control Strategy For Isolators

Modern contamination control links barrier design, bio-decontamination science, and risk-based validation to ensure reliable surface sterility.

 

Automating Manufacturing Of Tumor-Reactive T Cells

Uncover how CD137-based enrichment improves glioblastoma TIL manufacturing by expanding reactive T cell populations, preserving unique clonotypes, and strengthening autologous tumor cell killing.

 

Transform Monocyte Based Cell Therapy Manufacturing Via Elutriation

Fully automated, closed counterflow centrifugation systems streamline the manufacturing of monocyte-derived immunotherapies while maintaining product purity and cell viability.

 

Addressing The Misconceptions Of Custom Single-Use Adaptations

Single-use strategies and tools are constantly evolving to better serve industry needs, and adept solutions providers can help streamline development with simple, custom adaptations.

 

The Practical Guide To Ergonomic Liquid Handling

Even limited daily pipetting can increase the risk of repetitive strain injuries. Learn ways to improve posture, equipment selection, and workflow design while supporting long-term productivity.

SPONSOR

 

Webinar: Rethinking Starting Material: Whole Blood for Autologous T-Cell Manufacture

Could whole blood offer a practical alternative to leukapheresis for selected autologous T-cell therapy workflows? This webinar explores fit-for-purpose starting-material selection, cell requirements, recovery, processing logistics, and key variables such as hold time and anticoagulant choice. Learn how closed, automated cell-isolation approaches may help simplify processing, reduce patient burden, and support efficient, reproducible manufacturing across evolving cell therapy workflows. Click here to learn more.

MANUFACTURING SOLUTIONS

•

Harness The Power Of Pro: Advance Your Lab With Intelligence - Agilent Technologies

•

Choosing A Cell Expansion Platform - Terumo BCT

•

Automated, Single-Use System For Clinical And Commercial LNP Production - Cytiva

•

Reliable Magnetic Filter Funnels - Cytiva

•

Cell Sourcing - Comprehensive Cell Solutions, A Business Unit of NYBC Enterprises

•

Complete Organ-Chip Solutions To Fast-Track Your Drug Discovery - Emulate

Connect With Cell & Gene: